SE
Therapeutic Areas
1cBio Pipeline
| Drug | Indication | Phase |
|---|---|---|
| OC-1/ALE1 | Hypophosphatasia (HPP) | Phase 1/2a |
| OC-3 | Prostate, Ovarian, Breast, Pancreatic Cancers | Preclinical |
| CDK7 Inhibitors | Solid Tumors, Breast Cancer (incl. brain metastasis) | Discovery/Preclinical |
Leadership Team at 1cBio
AP
Andrew Protter, Ph.D.
CEO
SP
Son Pham, Ph.D.
Co-founder and Vice-President of Chemistry
PJ
Prashant Jain
CFO
SC
Sarvajit Chakravarty, Ph.D.
Co-founder (In Memoriam)
VB
V. Bryan Lawlis, Ph.D.
Board of Directors
EC
Eliza Chakravarty, M.D.
Board of Directors
AW
Andrew Wong
Board of Directors